Concert Pharmaceuticals Inc (CNCE) is around the top of the Biotechnology industry according to InvestorsObserver. CNCE received an overall rating of 85, which means that it scores higher than 85 percent of all stocks. Concert Pharmaceuticals Inc also achieved a score of 99 in the Biotechnology industry, putting it above 99 percent of Biotechnology stocks. Biotechnology is ranked 65 out of the 148 industries.
CNCE has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on CNCE!